תוצאות חיפוש - Taishi Harada
- Showing 1 - 16 results of 16
-
1
-
2
-
3
-
4
Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression מאת Heyan Li, Koichi Takayama, Shuo Wang, Yoshimasa Shiraishi, Keisuke Gotanda, Taishi Harada, Kazuto Furuyama, Eiji Iwama, Ichiro Ieiri, Isamu Okamoto, Yoichi Nakanishi
יצא לאור 2014Artigo -
5
Most T790M mutations are present on the same EGFR allele as activating mutations in patients with non–small cell lung cancer מאת Noriko Hidaka, Eiji Iwama, Naoki Kubo, Taishi Harada, Kohta Miyawaki, Kentaro Tanaka, Isamu Okamoto, Eishi Baba, Koichi Akashi, Hiroyuki Sasaki, Yoichi Nakanishi
יצא לאור 2017Artigo -
6
Histological evolution of pleuroparenchymal fibroelastosis מאת Takako Hirota, Yūji Yoshida, Yasuhiko Kitasato, Michihiro Yoshimi, Takaomi Koga, Nobuko Tsuruta, Masato Minami, Taishi Harada, Hiroshi Ishii, Masaki Fujita, Kazuki Nabeshima, Nobuhiko Nagata, Kentaro Watanabe
יצא לאור 2014Artigo -
7
The thoracic cage becomes flattened in the progression of pleuroparenchymal fibroelastosis מאת Taishi Harada, Yūji Yoshida, Yasuhiko Kitasato, Nobuko Tsuruta, Kentaro Wakamatsu, Takako Hirota, Makoto Tanaka, Naoki Tashiro, Hiroshi Ishii, Motokimi Shiraishi, Masaki Fujita, Nobuhiko Nagata, Kentaro Watanabe
יצא לאור 2014Carta -
8
Sensitivity and kinase activity of epidermal growth factor receptor (<scp>EGFR</scp>) exon 19 and others to <scp>EGFR</scp>‐tyrosine kinase inhibitors מאת Kazuto Furuyama, Taishi Harada, Eiji Iwama, Yoshimasa Shiraishi, Kyoko Okamura, Kayo Ijichi, Akiko Fujii, Keiichi Ota, Shuo Wang, Heyan Li, Koichi Takayama, Giuseppe Giaccone, Yoichi Nakanishi
יצא לאור 2013Artigo -
9
Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer מאת Keiichi Ota, Koichi Azuma, Akihiko Kawahara, Satoshi Hattori, Eiji Iwama, Junko Tanizaki, Taishi Harada, Koichiro Matsumoto, Koichi Takayama, Shinzo Takamori, Masayoshi Kage, Tomoaki Hoshino, Yoichi Nakanishi, Isamu Okamoto
יצא לאור 2015Artigo -
10
Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer מאת N. Iwai, Takashi Okuda, Junichi Sakagami, Taishi Harada, Tomoya Ohara, Masashi Taniguchi, Hiroaki Sakai, Kohei Oka, Tasuku Hara, Toshifumi Tsuji, Toshiyuki Komaki, Keizo Kagawa, Hiroaki Yasuda, Yuji Naito, Yoshito Itoh
יצא לאור 2020Artigo -
11
Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor-naïve patients with non–small cell lung cancer harboring <i>EGFR</i> mutati... מאת Kentaro Tanaka, Kaname Nosaki, Kohei Otsubo, Koichi Azuma, Shinya Sakata, Hiroshi Ouchi, Ryotaro Morinaga, Hiroshi Wataya, Akiko Fujii, Noriaki Nakagaki, Nobuko Tsuruta, Masafumi Takeshita, Eiji Iwama, Taishi Harada, Yoichi Nakanishi, Isamu Okamoto
יצא לאור 2017Artigo -
12
Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR‐mutated non‐small cell lung cancer מאת Tadaaki Yamada, Soichi Hirai, Yuki Katayama, Akihiro Yoshimura, Shinsuke Shiotsu, Satoshi Watanabe, Toshiaki Kikuchi, Kazuki Hirose, Yutaka Kubota, Yusuke Chihara, Taishi Harada, Keiko Tanimura, Takayuki Takeda, Nobuyo Tamiya, Yoshiko Kaneko, Junji Uchino, Koichi Takayama
יצא לאור 2019Artigo -
13
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L) מאת Hiroyuki Yamaguchi, Kazushige Wakuda, Minoru Fukuda, Hirotsugu Kenmotsu, Hiroshi Mukae, Kentaro Ito, Kenji Chibana, Kohji Inoue, Satoru Miura, Kentaro Tanaka, Noriyuki Ebi, Takayuki Suetsugu, Taishi Harada, Keisuke Kirita, Toshihide Yokoyama, Yuki Nakatani, Kenichi Yoshimura, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Kenji Sugio
יצא לאור 2021Artigo -
14
Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non‐small‐cell lung cancer מאת Kohei Otsubo, Kaname Nosaki, Chiyo K. Imamura, Hiroaki Ogata, Akitaka Fujita, Shinya Sakata, Fumihiko Hirai, Gouji Toyokawa, Eiji Iwama, Taishi Harada, Takashi Seto, Mitsuhiro Takenoyama, Takeshi Ozeki, Taisei Mushiroda, Mieko Inada, Junji Kishimoto, Kenji Tsuchihashi, Kentaro Suina, Osamu Nagano, Hideyuki Saya, Yoichi Nakanishi, Isamu Okamoto
יצא לאור 2017Artigo -
15
Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non−Small Cell Lung Cancer מאת Hayato Kawachi, Tadaaki Yamada, Motohiro Tamiya, Yoshiki Negi, Yasuhiro Gotô, Akira Nakao, Shinsuke Shiotsu, Keiko Tanimura, Takayuki Takeda, Asuka Okada, Taishi Harada, Koji Date, Yusuke Chihara, Isao Hasegawa, Nobuyo Tamiya, Masaki Ishida, Yuki Katayama, Kenji Morimoto, Masahiro Iwasaku, Shinsaku Tokuda, Takashi Kijima, Koichi Takayama
יצא לאור 2023Artigo -
16
Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu 1401) מאת Eiji Iwama, Yasushi Goto, Haruyasu Murakami, Taishi Harada, Shinsuke Tsumura, Hiroyuki Sakashita, Yoshiaki Mori, Noriaki Nakagaki, Yuka Fujita, Masahiro Seike, Akihiro Bessho, Manabu Ono, Akihito Okazaki, Hiroaki Akamatsu, Ryotaro Morinaga, Shinichiro Ushijima, Takayuki Shimose, Shoji Tokunaga, Akinobu Hamada, Nobuyuki Yamamoto, Yoichi Nakanishi, Kenji Sugio, Isamu Okamoto
יצא לאור 2017Artigo
כלי חיפוש:
נושאים קשורים
Medicine
Internal medicine
Cancer
Lung cancer
Oncology
Biology
Cancer research
Epidermal growth factor receptor
Gastroenterology
Genetics
Pathology
T790M
Chemotherapy
Erlotinib
Lung
Confidence interval
Gefitinib
Gene
Idiopathic pulmonary fibrosis
Immunotherapy
Interstitial lung disease
Molecular biology
Mutation
Performance status
Pharmacology
Receptor
Retrospective cohort study
Toxicity
ALK inhibitor
Adenocarcinoma